|
1
|
Lai NS, Wu DG, Fang XG, Lin YC, Chen SS,
Li ZB and Xu SS: Serum microRNA-210 as a potential noninvasive
biomarker for the diagnosis and prognosis of glioma. Br J Cancer.
112:1241–1246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sathornsumetee S and Rich JN: New
treatment strategies for malignant gliomas. Expert Rev Anticancer
Ther. 6:1087–1104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Delgado-López PD and Corrales-García EM:
Survival in glioblastoma: A review on the treatment modalities.
Clin Transl Oncol. 18:1062–1071. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hsiao J, Yuan TY, Tsai MS, Lu CY, Lin YC,
Lee ML, Lin SW, Chang FC, Liu Pimentel H, Olive C, et al:
Upregulation of haploinsufficient gene expression in the brain by
targeting a long non-coding RNA improves seizure phenotype in a
model of Dravet syndrome. EBioMedicine. 9:257–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung
JJ and Kwok TT: Oncofetal H19-derived miR-675 regulates tumor
suppressor RB in human colorectal cancer. Carcinogenesis.
31:350–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: LncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
|
12
|
Zhang XQ, Sun S, Lam KF, Kiang KM, Pu JK,
Ho AS, Lui WM, Fung CF, Wong TS and Leung GK: A long non-coding RNA
signature in glioblastoma multiforme predicts survival. Neurobiol
Dis. 58:123–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhi F, Wang Q, Xue L, Shao N, Wang R, Deng
D, Wang S, Xia X and Yang Y: The use of three long non-coding RNAs
as potential prognostic indicators of astrocytoma. PLoS One.
10:e01352422015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vital AL, Tabernero MD, Castrillo A,
Rebelo O, Tão H, Gomes F, Nieto AB, Resende Oliveira C, Lopes MC
and Orfao A: Gene expression profiles of human glioblastomas are
associated with both tumor cytogenetics and histopathology. Neuro
Oncol. 12:991–1003. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Zhou Y, Mehta KR, Danila DC,
Scolavino S, Johnson SR and Klibanski A: A pituitary-derived MEG3
isoform functions as a growth suppressor in tumor cells. J Clin
Endocrinol Metab. 88:5119–5126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang K, Sun X, Zhou X, Han L, Chen L, Shi
Z, Zhang A, Ye M, Wang Q, Liu C, et al: Long non-coding RNA HOTAIR
promotes glioblastoma cell cycle progression in an EZH2 dependent
manner. Oncotarget. 6:537–546. 2015.PubMed/NCBI
|
|
17
|
Benetatos L, Vartholomatos G and
Hatzimichael E: MEG3 imprinted gene contribution in tumourigenesis.
Int J Cancer. 129:773–779. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matouk IJ, Mezan S, Mizrahi A, Ohana P,
Abu-Lail R, Fellig Y, Degroot N, Galun E and Hochberg A: The
oncofetal H19 RNA connection: Hypoxia, p53 and cancer. Biochim
Biophys Acta. 1803:443–451. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo Q, Qian Z, Yan D, Li L and Huang L:
LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by
repressing Notch signaling. Biomed Pharmacother. 82:589–594. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou X, Ji G, Ke X, Gu H, Jin W and Zhang
G: miR-141 inhibits gastric cancer proliferation by interacting
with long noncoding RNA MEG3 and down-regulating E2F3 expression.
Dig Dis Sci. 60:3271–3282. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Liang X and Li Y: Long non-coding
RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and
inactivating PI3K/AKT pathway. Oncol Rep. 38:2408–2416. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qin N, Tong GF, Sun LW and Xu XL: Long
noncoding RNA MEG3 suppresses glioma cell proliferation, migration
and invasion by acting as a competing endogenous RNA of miR-19A.
Oncol Rep. 25:1471–1478. 2017. View Article : Google Scholar
|
|
23
|
Ma B, Gao Z, Lou J, Zhang H, Yuan Z, Wu Q,
Li X and Zhang B: Long non-coding RNA MEG3 contributes to
cisplatin-induced apoptosis via inhibition of autophagy in human
glioma cells. Mol Med Rep. 16:2946–2952. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie H, Fu JL and Xie C: miR-138-5p is
downregulated in patients with atrial fibrillation and reverses
cardiac fibrotic remodeling via repressing CYP11B2. Eur Rev Med
Pharmacol Sci. 22:4642–4647. 2018.PubMed/NCBI
|
|
25
|
Zhao X, Sun J, Chen Y, Su W, Shan H, Li Y,
Wang Y, Zheng N, Shan H and Liang H: LncRNA PFAR promotes lung
fibroblast activation and fibrosis by targeting miR-138 to regulate
the YAP1-Twist axis. Mol Ther. 26:2206–2217. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang L, Wang C, Lei F, Zhang L, Zhang X,
Liu A, Wu G, Zhu J and Song L: miR-93 promotes cell proliferation
in gliomas through activation of PI3K/Akt signaling pathway.
Oncotarget. 6:8286–8299. 2015.PubMed/NCBI
|
|
27
|
Ohta K, Hoshino H, Wang J, Ono S, Iida Y,
Hata K, Huang SK, Colquhoun S and Hoon DS: MicroRNA-93 activates
c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by
directly inhibiting PTEN and CDKN1A. Oncotarget. 6:3211–3224. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ke ZP, Xu P, Shi Y and Gao AM: MicroRNA-93
inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by
targeting PTEN. Oncotarget. 7:28796–28805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sullivan TB, Robert LC, Teebagy PA, Morgan
SE, Beatty EW, Cicuto BJ, Nowd PK, Rieger-Christ KM and Bryan DJ:
Spatiotemporal microRNA profile in peripheral nerve regeneration:
miR-138 targets vimentin and inhibits Schwann cell migration and
proliferation. Neural Regen Res. 13:1253–1262. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liang Z, Feng Q, Xu L, Li S and Zhou L:
CREPT regulated by miR-138 promotes breast cancer progression.
Biochem Biophys Res Commun. 493:263–269. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao H, Peng R, Liu Q, Liu D, Du P, Yuan
J, Peng G and Liao Y: The lncRNA H19 interacts with miR-140 to
modulate glioma growth by targeting iASPP. Arch Biochem Biophys.
610:1–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen L, Wang Y, He J, Zhang C, Chen J and
Shi D: Long non-coding RNA H19 promotes proliferation and invasion
in human glioma cells by downregulating miR-152. Oncol Res. Feb
8–2018.doi: 10.3727/096504018X15178768577951 (Epub ahead of print).
View Article : Google Scholar
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang S and Qi Q: MTSS1 suppresses cell
migration and invasion by targeting CTTN in glioblastoma. J
Neurooncol. 121:425–431. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang J, Li Y, Sang Y, Yu B, Lv D, Zhang W
and Feng H: LncRNA PVT1 regulates triple-negative breast cancer
through KLF5/beta-catenin signaling. Oncogene. 37:4723–4734. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao L, Han T, Li Y, Sun J, Zhang S, Liu
Y, Shan B, Zheng D and Shi J: The lncRNA SNHG5/miR-32 axis
regulates gastric cancer cell proliferation and migration by
targeting KLF4. FASEB J. 31:893–903. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lü MH, Tang B, Zeng S, Hu CJ, Xie R, Wu
YY, Wang SM, He FT and Yang SM: Long noncoding RNA BC032469, a
novel competing endogenous RNA, upregulates hTERT expression by
sponging miR-1207-5p and promotes proliferation in gastric cancer.
Oncogene. 35:3524–3534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yan C, Jiang Y, Wan Y, Zhang L, Liu J,
Zhou S and Cheng W: Long noncoding RNA NBAT-1 suppresses
tumourigenesis and predicts favorable prognosis in ovarian cancer.
Onco Targets Ther. 10:1993–2002. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pandey GK, Mitra S, Subhash S, Hertwig F,
Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S,
et al: The risk-associated long noncoding RNA NBAT-1 controls
neuroblastoma progression by regulating cell proliferation and
neuronal differentiation. Cancer Cell. 26:722–737. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang J, Guo S and Jia B: Down-regulation
of long non-coding RNA MEG3 serves as an unfavorable risk factor
for survival of patients with breast cancer. Eur Rev Med Pharmacol
Sci. 20:5143–5147. 2016.PubMed/NCBI
|
|
43
|
Luo G, Wang M, Wu X, Tao D, Xiao X, Wang
L, Min F, Zeng F and Jiang G: Long non-coding RNA MEG3 inhibits
cell proliferation and induces apoptosis in prostate cancer. Cell
Physiol Biochem. 37:2209–2220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu G, Zhao X, Zhou J, Cheng X, Ye Z and
Ji Z: Long non-coding RNA MEG3 suppresses the development of
bladder urothelial carcinoma by regulating miR-96 and TPM1. Cancer
Biol Ther. 19:1039–1056. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Guo Y, Liu H, Zhang H, Shang C and Song Y:
miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer.
Oncol Lett. 4:561–565. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lee YG, Macoska JA, Korenchuk S and Pienta
K: MIM, a potential metastasis suppressor gene in bladder cancer.
Neoplasia. 4:291–294. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu K, Wang G, Ding H, Chen Y, Yu G and
Wang J: Downregulation of metastasis suppressor 1 (MTSS1) is
associated with nodal metastasis and poor outcome in Chinese
patients with gastric cancer. BMC Cancer. 10:4282010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Parr C and Jiang WG: Metastasis suppressor
1 (MTSS1) demonstrates prognostic value and anti-metastatic
properties in breast cancer. Eur J Cancer. 45:1673–1683. 2009.
View Article : Google Scholar : PubMed/NCBI
|
